1) Gongjingai suppository
宫颈癌栓
1.
OBJECTIVE:To establish an HPLC method for content determination of Pedatisectin B in Gongjingai suppository.
目的:建立以高效液相色谱法测定宫颈癌栓中掌叶半夏碱乙含量的方法。
2) Gongjingning suppository
宫颈宁栓
3) cervix uteri suppository
宫颈栓
4) cervical carcinoma
宫颈癌
1.
Inhibitory effect of matrine on human cervical carcinoma Hela cells in vitro;
中药苦参碱对体外培养人宫颈癌Hela细胞的抑制作用
2.
The effect of interventional therapy in combination with surgical operation for stage middle-advanced cervical carcinoma;
介入化疗在中晚期宫颈癌综合治疗中的临床应用
3.
Expressions of HIF-1α and p53 in cervical carcinoma and intraepithelial neoplasia;
低氧诱导因子-1α和p53蛋白在宫颈癌中的表达
5) Cervical carcinoma
子宫颈癌
1.
Abnormal expression of fragile histidine triad protein expression in cervical carcinoma and CIN in Xinjiang women;
新疆妇女子宫颈癌及子宫颈上皮内瘤变组织FHIT蛋白表达及其意义
2.
Study of loss of imprinting of insulin-like growth factor Ⅱ and H19 genes in cervical carcinoma;
印记基因H19和胰岛素样生长因子Ⅱ在人子宫颈癌组织中印记缺失及意义
3.
Effect of anti-proliferation of curcumin on cervical carcinoma HeLa cells and its mechanism;
姜黄素对子宫颈癌HeLa细胞增殖抑制作用及其机制的研究
6) cervical carcinoma
宫颈鳞癌
1.
The expressions of Bag-1 and HSP70 protein in cervical intraepithelial neoplasia and cervical carcinoma
Bag-1、HSP70蛋白在宫颈上皮内瘤变及宫颈鳞癌中的表达和意义
2.
Objective:To research P120-catenin(P120ctn)and E-cadherin(E-cad)abnormal expression,distribution and biologic significance in samples of squamous cervical carcinoma(SCC)and SCC cell lines(Caski、Siha).
目的:探讨P120连环蛋白(P120catenin,P120ctn)及E-钙粘蛋白(E-cad-herin,E-cad)在宫颈鳞癌组织和宫颈鳞癌细胞系(Caski、Siha)中的表达、分布及其生物学意义。
3.
Objective To search a new method for screening high-risk group of cervical carcinoma.
方法免疫组织化学技术检测13例慢性宫颈炎、46例不同程度宫颈不典型增生、15例原位癌和20例宫颈鳞癌组织中瘦素的表达情况,同时免疫细胞化学技术检测以上各病例宫颈脱落细胞中瘦素的表达。
补充资料：宫颈复发癌
宫颈复发癌
多发生于晚期宫颈癌(包括局部晚期)治疗后，也有报告浸润性宫颈癌治疗后约有35%复发。复发性宫颈癌的治疗困难，预后差，是宫颈癌死亡最重要的原因。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条